The challenge lies in selectively targeting the detrimental aspects of p38 signaling without compromising the beneficial functions, necessitating further research and a more comprehensive understanding of the intricate interplay between diverse cell types and signaling pathways implicated in COPD pathogenesis [113]. The gene discussed is MAPK14; the disease is chronic obstructive pulmonary disease.